19 May 2013
Keywords: novartis, files, exjade, usa, eu, switzerland, leading
Article | 09 May 2005
Novartis, Switzerland's leading pharmaceutical firm, has filed Exjade (deferasirox), the first and only once-daily oral iron chelator for the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 May 2005
16 May 2005
17 May 2013
© 2013 thepharmaletter.com